Berta Hernández

594 total citations
17 papers, 352 citations indexed

About

Berta Hernández is a scholar working on Oncology, Pulmonary and Respiratory Medicine and General Health Professions. According to data from OpenAlex, Berta Hernández has authored 17 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in General Health Professions. Recurrent topics in Berta Hernández's work include Lung Cancer Treatments and Mutations (7 papers), Patient Satisfaction in Healthcare (5 papers) and Patient-Provider Communication in Healthcare (5 papers). Berta Hernández is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Patient Satisfaction in Healthcare (5 papers) and Patient-Provider Communication in Healthcare (5 papers). Berta Hernández collaborates with scholars based in Spain, United Kingdom and France. Berta Hernández's co-authors include Maite Martínez, Ruth Vera, David Escors, Hugo Arasanz, María José Lecumberri, Idoia Morilla, Grazyna Kochan, Lucía Teijeira, María Gato and Ana Bocanegra and has published in prestigious journals such as Journal of Clinical Oncology, Oncotarget and Psycho-Oncology.

In The Last Decade

Berta Hernández

15 papers receiving 352 citations

Peers

Berta Hernández

ONCOL

IMMUN

PRM

GHP

María José Lecumberri Spain

Jared D. Acoba United States

Kim Ryan Australia

Pauline Evers Netherlands

Rashmi Kumar United States

Mary Lou Ernest United States

Humera Khurshid United States

Kenneth D. Bishop United States

Erlene Seymour United States

Maike Trommer Germany

María José Lecumberri Spain

Berta Hernández

224 ×0.9

ONCOL

123 ×1.1

IMMUN

93 ×1.2

PRM

31 ×0.5

GHP

38 ×0.9

Citations per year, relative to Berta Hernández Berta Hernández (= 1×) peers María José Lecumberri

Countries citing papers authored by Berta Hernández

Since Specialization

Citations

This map shows the geographic impact of Berta Hernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berta Hernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berta Hernández more than expected).

Fields of papers citing papers by Berta Hernández

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berta Hernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berta Hernández. The network helps show where Berta Hernández may publish in the future.

Co-authorship network of co-authors of Berta Hernández

This figure shows the co-authorship network connecting the top 25 collaborators of Berta Hernández. A scholar is included among the top collaborators of Berta Hernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berta Hernández. Berta Hernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Galéra, Philippe, Luís Manso, A. Zapatero, et al.. (2025). Immunoprofiling: A prospective multi-cohort study to characterize circulating immune response in advanced prostate cancer.. Journal of Clinical Oncology. 43(16_suppl).

Arasanz, Hugo, Miren Zuazo, Ana Bocanegra, et al.. (2020). Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics. Cancers. 12(2). 344–344. 58 indexed citations

Franco, Fernando, Carlos García Girón, Manuel Dómine, et al.. (2020). Clinical and molecular characteristics of the patients in the liquid biopsy study in mEGFR-NSCLC in a Spanish population (OPH-1).. Journal of Clinical Oncology. 38(15_suppl). e21515–e21515. 1 indexed citations

Hernández, Berta, et al.. (2020). 5PSQ-074 Fampridine related atrial fibrillation: two case reports. A184.1–A184.

Romero, Atocha, Miguel Ángel Molina‐Vila, Eloísa Jantus‐Lewintre, et al.. (2020). Comprehensive cross-platform comparison of methodologies for noninvasive EGFR mutation testing: Results of the RING observational trial.. Journal of Clinical Oncology. 38(15_suppl). e21518–e21518. 1 indexed citations

Franco, Fernando, Carlos García Girón, Manuel Dómine, et al.. (2020). ctDNA levels before treatment predict survival in non-small cell lung cancer patients treated with a tyrosine kinase inhibitor.. Journal of Clinical Oncology. 38(15_suppl). 9542–9542. 2 indexed citations

Zuazo, Miren, Hugo Arasanz, G. Fernández-Hinojal, et al.. (2019). Functional systemic CD 4 immunity is required for clinical responses to PD ‐L1/ PD ‐1 blockade therapy. EMBO Molecular Medicine. 11(7). e10293–e10293. 143 indexed citations

Martı́nez, Enrique, M. Rico, Maite Martínez, et al.. (2016). Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial. OncoTargets and Therapy. 9. 1057–1057. 13 indexed citations

Arrarás, Juan Ignacio, Berta Hernández, Maite Martínez, et al.. (2016). Quality of Life in Spanish advanced non-small-cell lung cancer patients: determinants of global QL and survival analyses. SpringerPlus. 5(1). 836–836. 11 indexed citations

10.

Blanco‐Luquin, Idoia, Berta Ibáñez, Berta Hernández, et al.. (2015). EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas. Oncotarget. 6(1). 368–380. 23 indexed citations

11.

Hernández, Berta, Maite Martínez, Lucía Teijeira, et al.. (2014). Crizotinib in advanced ALK-positive non-small cell lung cancer: Results of a retrospective cohort in Complejo Hospitalario de Navarra, Spain.. Journal of Clinical Oncology. 32(15_suppl). e19158–e19158. 2 indexed citations

12.

Arrarás, Juan Ignacio, José Juan Illarramendi, A. Viúdez, et al.. (2013). Determinants of patient satisfaction with care in a Spanish oncology Day Hospital and its relationship with quality of life. Psycho-Oncology. 22(11). 2454–2461. 24 indexed citations

13.

Arrarás, Juan Ignacio, José Juan Illarramendi, A. Viúdez, et al.. (2012). The cancer outpatient satisfaction with care questionnaire for chemotherapy, OUT-PATSAT35 CT: a validation study for Spanish patients. Supportive Care in Cancer. 20(12). 3269–3278. 15 indexed citations

14.

Arrarás, Juan Ignacio, Berta Hernández, Fernando Arias de la Vega, et al.. (2011). The EORTC information questionnaire, EORTC QLQ-INFO25. Validation study for Spanish patients. Clinical & Translational Oncology. 13(6). 401–410. 15 indexed citations

15.

Arrarás, Juan Ignacio, Ruth Vera, Maite Martínez, et al.. (2009). The EORTC cancer in-patient satisfaction with care questionnaire: EORTC IN-PATSAT32. Clinical & Translational Oncology. 11(4). 237–242. 20 indexed citations

16.

Arrarás, Juan Ignacio, M. Rico, Gemma Asín, et al.. (2009). The EORTC cancer outpatient satisfaction with care questionnaire in ambulatory radiotherapy: EORTC OUT‐PATSAT35 RT. Validation study for Spanish patients. Psycho-Oncology. 19(6). 657–664. 20 indexed citations

17.

Cortés, Javier, Javier Rodríguez, Emiliano Calvo, et al.. (2004). Paclitaxel, Cisplatin, and Vinorelbine Combination Chemotherapy in Metastatic Non–Small-Cell Lung Cancer. American Journal of Clinical Oncology. 27(3). 299–303. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact